These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 564661)

  • 1. The role of glycosylation in the enzymatic conversion of procollagen to collagen: studies using tunicamycin and concanavalin A.
    Duksin D; Davidson JM; Bornstein P
    Arch Biochem Biophys; 1978 Jan; 185(2):326-32. PubMed ID: 564661
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effects of tunicamycin on procollagen biosynthesis and secretion.
    Tanzer ML; Rowland FN; Murray LW; Kaplan J
    Biochim Biophys Acta; 1977 Nov; 500(1):187-96. PubMed ID: 562681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired conversion of procollagen to collagen by fibroblasts and bone treated with tunicamycin, an inhibitor of protein glycosylation.
    Duksin D; Bornstein P
    J Biol Chem; 1977 Feb; 252(3):955-62. PubMed ID: 838706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procollagen: conversion of the precursor to collagen by a neutral protease.
    Bornstein P; Ehrlich HP; Wyke AW
    Science; 1972 Feb; 175(4021):544-6. PubMed ID: 5008597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of carbohydrates in protein secretion and turnover: effects of tunicamycin on the major cell surface glycoprotein of chick embryo fibroblasts.
    Olden K; Pratt RM; Yamada KM
    Cell; 1978 Mar; 13(3):461-73. PubMed ID: 657267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of type II procollagen to collagen. Extracellular removal of the amino-terminal and carboxy-terminal extensions without a preferential sequence.
    Uitto J; Allan RE; Polak KL
    Eur J Biochem; 1979 Aug; 99(1):97-103. PubMed ID: 573690
    [No Abstract]   [Full Text] [Related]  

  • 7. Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome.
    Lichtenstein JR; Martin GR; Kohn LD; Byers PH; McKusick VA
    Science; 1973 Oct; 182(4109):298-300. PubMed ID: 4742738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis of type II collagen. Removal of amino-and carboxy-terminal extensions from procollagen synthesized by chick embryo cartilage cells.
    Uitto J
    Biochemistry; 1977 Jul; 16(15):3421-9. PubMed ID: 407928
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of betamethasone-17-valerate on synthesis of collagen and prolyl hydroxylase activity in chick embryo tendon cells.
    Oikarinen A
    Biochem Pharmacol; 1977 May; 26(9):875-9. PubMed ID: 193518
    [No Abstract]   [Full Text] [Related]  

  • 10. Intermediates in the conversion of procollagen to collagen. Evidence for stepwise limited proteolysis of the COOH-terminal peptide extensions.
    Davidson JM; McEneany LS; Bornstein P
    Eur J Biochem; 1977 Dec; 81(2):349-55. PubMed ID: 202456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method for the measurement and characterization of protease activities responsible for extracellular or intracellular degradation of collagen precursors.
    Farjanel J; Rattner A; Pujol P; Cordier S
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1002-11. PubMed ID: 6091644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procollagen processing. Limited proteolysis of COOH-terminal extension peptides by a cathepsin-like protease secreted by tendon fibroblasts.
    Davidson JM; McEneany LS; Bornstein P
    Eur J Biochem; 1979 Oct; 100(2):551-8. PubMed ID: 41715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-dependent conversion of procollagen to collagen and its inhibition by other divalent cations.
    Oikarinen AI; Zaragoza EJ; Ryhänen L; Uitto J
    Biochem Pharmacol; 1984 Feb; 33(4):695-7. PubMed ID: 6704190
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of desmosome formation with tunicamycin and with lectin in corneal cell aggregates.
    Overton J
    Dev Biol; 1982 Jul; 92(1):66-72. PubMed ID: 7106388
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in surface properties of normal and transformed cells caused by tunicamycin, an inhibitor of protein glycosylation.
    Duksin D; Bornstein P
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3433-7. PubMed ID: 198786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of type II procollagen to collagen conversion by lysine derivatives and related compounds. Mapping of the inhibitory structural features.
    Zaragoza EJ; Ryhänen L; Oikarinen AI; Uitto J
    Biochem Pharmacol; 1986 Feb; 35(3):532-5. PubMed ID: 3081007
    [No Abstract]   [Full Text] [Related]  

  • 17. Concomitant hydroxylation of proline and lysine residues in collagen using purified enzymes in vitro.
    Turpeenniemi-Hujanen T; Myllylä R
    Biochim Biophys Acta; 1984 Jul; 800(1):59-65. PubMed ID: 6331520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of type II procollagen to collagen in vitro: removal of the carboxy-terminal extension is inhibited by several naturally occurring amino acids, polyamines, and structurally related compounds.
    Ryhänen L; Tan EM; Rantala-Ryhänen S; Uitto J
    Arch Biochem Biophys; 1982 Apr; 215(1):230-6. PubMed ID: 7092227
    [No Abstract]   [Full Text] [Related]  

  • 19. Tunicamycin treated fibroblasts secrete a cathepsin B-like protease.
    Parent JB; Bauer HC; Olden K
    Biochem Biophys Res Commun; 1982 Sep; 108(2):552-8. PubMed ID: 6756402
    [No Abstract]   [Full Text] [Related]  

  • 20. Procollagen polypeptides containing cis-4-hydroxy-L-proline are overglycosylated and secreted as nonhelical pro-gamma-chains.
    Uitto VJ; Uitto J; Kao WW; Prockop DJ
    Arch Biochem Biophys; 1978 Jan; 185(1):214-21. PubMed ID: 623484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.